The authors draw on recent analyses showing that guideline implementation in low- and middle-income settings frequently collides with systemic barriers, including limited staffing, constrained infrastructure, fragmented care pathways, and difficulty keeping recommendations current or applying them consistently. In such contexts, the gap between efficacy and effectiveness widens dramatically. An intervention that performs beautifully under the controlled conditions of a well-funded trial may fail to deliver meaningful benefit when the surrounding ecosystem cannot support its safe implementation. This is not a marginal concern. Middle-income countries serve billions of people, and their hospitals increasingly face pressure to adopt the same cutting-edge standards promoted by international guideline bodies, even when the local scaffolding required to make those standards work is missing.

Mechanical ventilation provides one of the most striking illustrations of the problem. Debates about ventilator asynchronies, optimal driving pressure, fine-tuning of positive end-expiratory pressure, and advanced weaning strategies are scientifically relevant and clinically valuable in mature systems. But their relative importance shifts dramatically when baseline mortality among ventilated patients is extremely high. In a Brazilian university hospital cohort, mortality among mechanically ventilated patients reached 51 percent. In a nationwide analysis of the first 250,000 COVID-19 admissions in Brazil, mortality among invasively ventilated patients approached 80 percent. Under such circumstances, the authors argue, the most impactful intervention may not be refining ventilator settings at all, but rather stepping back to strengthen upstream and downstream processes: avoiding both delayed and unnecessary intubations, scaling up staff training, cutting down deep sedation, and rolling out structured liberation protocols.

The lesson here is counterintuitive but powerful. When outcomes are overwhelmingly poor, incremental physiological optimization may matter less than systemic redesign. A hospital struggling to keep ventilated patients alive at rates far worse than international benchmarks gains little from adopting the latest evidence on driving pressure thresholds if its fundamental processes of care remain broken. The viewpoint suggests that clinicians and policymakers in these settings face a triage problem of their own: not which patient to treat first, but which improvement to pursue first. And the answer, more often than not, lies in the unglamorous machinery of healthcare delivery rather than in the frontier of critical care science.

Surgical oncology raises similarly uncomfortable questions. It is entirely legitimate to debate the optimal perioperative or adjuvant therapy after esophagectomy, one of the most demanding operations in cancer medicine. Yet those discussions lose practical traction when perioperative mortality remains high because of limited capacity to rescue patients from complications. In the international OGAA cohort, patients undergoing esophagectomy in low- and middle-income countries experienced 90-day mortality of 9.4 percent, compared with 3.7 percent in high-income settings, despite similar rates of major complications. This discrepancy strongly suggests a failure-to-rescue phenomenon: patients suffer the same complications everywhere, but in some hospitals the systems needed to detect deterioration early and intervene decisively simply are not there.

The implications of that finding are stark. In hospitals where perioperative mortality approaches 30 percent, the authors write, it becomes ethically and organizationally necessary to ask whether centralization of care, volume consolidation, and investment in multidisciplinary perioperative pathways should take precedence over debates about the newest immunotherapy regimen. A patient operated on in a low-volume facility without robust rescue capacity faces a fundamentally different risk profile than a patient with the same tumor treated in a high-volume center, regardless of which drug regimen follows the surgery. The ethical dimension is hard to escape: offering the most advanced therapy within a fragile system may be less defensible than ensuring the patient survives the operation itself.

Stroke care offers another perspective on what the authors call contextual effectiveness. Establishing dedicated stroke teams and stroke units is widely recommended worldwide, yet their benefit in resource-limited environments often stems less from high-technology reperfusion therapies and more from getting the basics right. Evidence highlights the importance of early dysphagia screening, prevention of aspiration pneumonia, early mobilization, nutritional support, and coordinated discharge planning. Brazilian data indicate that dysphagia occurs in up to 76 percent of stroke patients and is associated with markedly increased pneumonia risk, and a recent meta-analysis confirmed that post-stroke dysphagia is linked to higher odds of pneumonia and mortality. The question, therefore, is not whether stroke units are worthwhile, but how they are structured. Units that focus narrowly on imaging and thrombolysis while overlooking fundamental supportive care may appear modern without actually being effective.

Sepsis management perhaps most clearly illustrates the limits of guideline transferability. The Surviving Sepsis Campaign has played a pivotal role in standardizing sepsis care across the globe, yet even its own recommendations acknowledge variability in resource availability across settings. The randomized trial by Andrews and colleagues in Zambia demonstrated that an early resuscitation protocol incorporating aggressive fluid administration, vasopressors, and transfusion actually increased in-hospital mortality compared with usual care. Similarly, the landmark FEAST trial showed that fluid boluses increased short-term mortality among African children with severe infection in environments lacking equivalent critical care support. These findings do not invalidate sepsis physiology or the global guidelines built upon it. Rather, they underscore a sobering principle: interventions proven beneficial in resource-rich contexts may turn harmful when scaled up without the infrastructure required to carry them through safely.

From these examples, the authors construct a more nuanced hierarchy of priorities. First-order priorities include adequate staffing, early recognition of deterioration, prevention of complications, timely access to antibiotics and oxygen, safe airway management, nutritional support, rehabilitation, and effective teamwork. Second-order priorities involve fine-tuning advanced therapies once basic systems are functioning reliably. Too often, they argue, health systems in middle-income countries attempt to import second-order debates into environments where first-order problems remain unresolved. This mismatch, they insist, is not merely technical but ethical. A more mature use of evidence-based medicine in such contexts may require filtering every recommendation through three lenses: external validity, implementation feasibility, and opportunity cost. If aspiration pneumonia after stroke remains common, investing in dysphagia screening and nursing training may yield greater benefit than adopting sophisticated imaging algorithms. If perioperative mortality remains high, strengthening rescue capacity may matter more than selecting the latest targeted therapy. If septic patients die because they cannot access timely airway support or monitoring, strict adherence to care bundles may not address the core failure.

Ultimately, the viewpoint concludes that evidence does work in countries like Brazil, but not as a plug-and-play solution. Its real-world effectiveness hinges on the resilience of the system that sustains it. Guidelines are most valuable when they help clinicians and policymakers sort out priorities, spell out prerequisites, and avoid decontextualized interventions. In fragile settings, the authors suggest, true sophistication may lie not in scaling up the newest recommendation but in stepping back to ask the right question at the right time. Often, that question is not which advanced therapy should come next, but rather why the system is still falling short on the basics. For a global medical community increasingly shaped by shared guidelines and universal benchmarks, that reframing may be the most important prescription of all.

Subject of Research: Contextual effectiveness and transferability of evidence-based clinical guidelines in middle-income health systems

Article Title: Does Evidence Travel Well? Rethinking Guidelines and Real-World Effectiveness in Middle-Income Health Systems

Article References: Felice, V. B., & Teixeira, C. (2026). Does Evidence Travel Well? Rethinking Guidelines and Real-World Effectiveness in Middle-Income Health Systems. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-026-10867-9

Image Credits: AI Generated

DOI: 10.1007/s11606-026-10867-9

Keywords: evidence-based medicine, clinical guidelines, middle-income countries, global health, mechanical ventilation, sepsis, stroke care, surgical oncology, failure to rescue, health systems, Brazil, implementation science

Minimally invasive esophagectomy, or MIE, replaces the large incisions of conventional open surgery with thoracoscopic and laparoscopic techniques, aiming to reduce trauma to the chest and abdominal wall while still removing the esophagus and reconstructing the digestive tract. Since the first reported case by Cuschieri and colleagues in 1992, the approach has spread rapidly around the world. In Japan, where esophageal cancer remains one of the more common and lethal malignancies, the proportion of esophagectomies performed minimally invasive rose from just 2 percent in 1996 to 57 percent by 2016, according to national surgical registries. That steep adoption curve reflects advances in instrumentation, the widespread uptake of the prone position for the thoracic phase, and insurance coverage introduced in 2002.

Yet esophagectomy in any form remains one of the most demanding operations in gastrointestinal surgery, and MIE demands even greater technical skill. The operation requires mobilizing the esophagus deep within the mediastinum, performing extensive lymph node dissection near the recurrent laryngeal nerves and airway, and then fashioning a new conduit from the stomach. Given these challenges, the question of whether hospitals that rarely perform the procedure achieve comparable results has been a persistent concern for surgeons and policymakers alike.

The scientific lineage of the volume-outcome question stretches back to 1979, when Luft and colleagues first documented that surgical mortality declines as hospital case volume rises across a range of procedures. Begg and colleagues focused specifically on esophagectomy in 1998, followed by Swisher, van Lanschot, and Birkmeyer, each using different volume thresholds but each reaching the same directional conclusion: the lowest-volume hospitals consistently posted the highest death rates. Japanese investigators, including Kazui and later Nishigori, confirmed similar patterns in national data. What remained unknown was whether these findings, based on open surgery or mixed populations, applied to MIE performed exclusively.

To answer that question, the research team turned to the National Clinical Database, a rigorously audited nationwide registry developed in cooperation with Japan’s surgical board certification system. The database enforces standardized definitions of morbidity and mortality and maintains continuous data verification. The investigators included patients with thoracic esophageal cancer who underwent transthoracic subtotal esophagectomy with reconstruction, defining MIE as either a totally thoracoscopic and laparoscopic approach or a hybrid combining thoracoscopy with open laparotomy. Of the 22,712 eligible cases, 9,739, or 42.9 percent, were performed minimally invasively.

Hospitals were stratified into five categories by their average annual esophagectomy volume, counting both open and minimally invasive operations to capture total institutional experience: very low (1 to 5 cases per year), low (6 to 10), medium (11 to 20), high (21 to 40), and very high (41 or more). The distribution was heavily skewed. Nearly three quarters of all hospitals fell into the very low category, while only 26 institutions performed 41 or more esophagectomies annually. Meanwhile, MIE adoption rose steadily with volume, from 27.9 percent of operations at very low-volume hospitals to roughly 45 to 50 percent at the higher-volume tiers, suggesting that minimally invasive techniques concentrated early in busier centers.

The raw outcomes were unambiguous. Overall operative mortality for MIE across the study period was 2.1 percent, but it ranged from 1.2 percent at very high-volume hospitals to 3.9 percent at very low-volume centers. After adjusting for patient age, comorbidities, American Society of Anesthesiologists class, preoperative therapy, and tumor stage using hierarchical logistic regression, patients at very low-volume hospitals faced 2.70 times the odds of death compared with those at very high-volume hospitals, a difference that was highly statistically significant. Medium-volume hospitals also showed a modest but significant elevation in risk, with an odds ratio of 1.70, while the differences at low and high-volume hospitals did not reach statistical significance.

Intriguingly, the overall complication rate, which averaged 40.9 percent, varied far less across hospital tiers, from 38.7 percent at the busiest centers to 44.2 percent at the least busy, and the adjusted analysis found no significant volume effect on total complications. This dissociation between complications and mortality points toward what surgical health services researchers call failure to rescue: the capacity of an institution to recognize and effectively manage a complication once it arises. Prior work by Abdelsattar and colleagues found that 21.2 percent of patients with major complications died before discharge at low-volume hospitals, compared with 13.4 percent at high-volume hospitals, a gap attributed to differences in evidence-based care processes and structural resources such as dedicated surgical intensive care units and multidisciplinary teams.

The complication-specific analyses sharpened this picture. Anastomotic leakage, one of the most feared complications of esophageal reconstruction, was significantly more likely at very low-volume hospitals, with an adjusted odds ratio of 2.23 relative to very high-volume centers, and remained elevated at both low and high-volume tiers. Atelectasis was also significantly more common at very low-volume hospitals. By contrast, rates of postoperative pneumonia, recurrent laryngeal nerve paralysis, and chylothorax showed no significant volume association, hinting that the core technical execution of MIE has become fairly standardized across Japan. Consistent with that interpretation, operative time and intraoperative blood loss were broadly similar across hospital tiers, while postoperative length of tellingly fell from a median of 30 days at very low-volume hospitals to 21 days at very high-volume centers, a difference the authors attribute partly to more effective perioperative management.

The study period itself was a deliberate choice. Between 2012 and 2015, Japanese esophageal surgery was undergoing its steepest transition toward minimally invasive techniques, with institutional experience varying enormously. The authors argue this transitional window makes the volume effect especially visible. Their analysis also situates the findings within an international debate over volume thresholds. The Leapfrog Group in the United States progressively raised its recommended minimum to 20 esophagectomies per year by 2018, while Japanese researcher Fujita and colleagues identified fewer than 5 cases per year as the risky threshold in an earlier national analysis, a figure closely matching the present study’s definition of very low-volume hospitals.

The implications for policy are nuanced rather than simplistic. Centralizing all MIE to a handful of high-volume centers could save lives, but it would impose geographic burdens on patients in rural regions and may be impractical in a country with a dispersed hospital network. The authors suggest alternative safeguards: paying close attention to surgeon-level volume, which Birkmeyer and colleagues showed explains nearly half of the hospital volume effect on mortality, and ensuring that operations and perioperative care are led by board-certified esophageal surgery specialists. In Japan, senior surgeons at high-volume hospitals frequently supervise less experienced colleagues, and multidisciplinary conferences may spread expertise beyond the operating surgeon, which could explain why earlier Japanese studies found hospital volume mattered while individual surgeon volume did not.

The authors acknowledge important limitations. The registry did not capture institutional factors such as hospital size, intensive care staffing, or the presence of certified esophageal surgeons, any of which could mediate the volume-outcome relationship. Long-term survival, the ultimate measure of cancer care, was not assessed, although prior meta-analytic work by Brusselaers and colleagues suggests high-volume settings confer an 18 to 25 percent survival advantage that persists even after excluding early postoperative deaths. Residual confounding from patient frailty and nutritional status also cannot be excluded despite extensive risk adjustment.

Even with those caveats, the central message lands with force. Patients facing minimally invasive esophagectomy at hospitals that perform the operation only a handful of times a year, roughly once every two to three months, carry a substantially elevated risk of dying from the procedure itself. As minimally invasive esophagectomy continues its global march toward becoming the default approach for esophageal cancer, this study of nearly ten thousand Japanese patients offers a data-driven benchmark: somewhere around five cases a year, institutional experience appears to cross a line separating acceptable outcomes from avoidable deaths.

Subject of Research: The relationship between hospital surgical volume and postoperative outcomes of minimally invasive esophagectomy for esophageal cancer

Article Title: Relationship Between Hospital Volume and Outcomes of Minimally Invasive Esophagectomy for Esophageal Cancer: Analysis of the National Clinical Database in Japan

Article References: Ozawa, S., Kumamaru, H., Kitagawa, Y., Koyanagi, K., Oguma, J., Udagawa, H., Miyata, H., Toh, Y., & Matsubara, H. (2026). Relationship Between Hospital Volume and Outcomes of Minimally Invasive Esophagectomy for Esophageal Cancer: Analysis of the National Clinical Database in Japan. Annals of Gastroenterological Surgery, 10(5), 1518-1526. https://doi.org/10.1002/ags3.70229

Image Credits: AI Generated

DOI: 10.1002/ags3.70229

Keywords: esophageal cancer, minimally invasive esophagectomy, hospital volume, surgical mortality, National Clinical Database, failure to rescue, anastomotic leakage, postoperative complications, thoracic surgery, Japan, volume-outcome relationship, surgical outcomes